New artificial pancreas uses two hormones instead of one
The JDRF Artificial Pancreas Consortium has made significant advancements in their quest to develop a safe and effective automated diabetes management system, with trials already showing it is possible to maintain healthy blood glucose levels in people with type 1 diabetes without the need for human intervention.
To date, the closed-loop systems tested have combined an insulin pump with glucose monitoring and complex computer programs designed to predict and activate insulin release as required. Whilst results of these trials have been overwhelmingly positive, researchers have found it to be more difficult than first anticipated to finely tune blood glucose levels – particularly when protecting patients against potentially dangerous hypoglycemia caused by too much insulin.
10 Comments 
